Latest News
Karyopharm seeks accelerated FDA approval for selinexor–ruxolitinib in myelofibrosis
31 August 2026 - US pharmaceutical company Karyopharm Therapeutics Inc. (NASDAQ: KPTI) said on Monday it has submitted a supplemental New Drug Application to the US Food and Drug Administration for Accelerated Approval of XPOVIO (selinexor) combined ...
Lilly to acquire Merida Biosciences in USD2.875bn deal
31 August 2026 - US pharmaceutical company Eli Lilly and Company (NYSE: LLY) on Monday announced that it has agreed to acquire Merida Biosciences, Inc., a biotechnology business developing precision biologics for autoimmune and allergic diseases.The ...
Harvest Integrated Research Organization signs MoU with Differentia Biotech
31 August 2026 - Harvest Integrated Research Organization (HiRO), a full-service global clinical research organisation, announced on Friday that it has signed a Memorandum of Understanding (MOU) for its collaboration with Differentia Biotech Ltd. (&#...
Formosa Pharmaceuticals submits Clinical Trial Application to European regulatory authorities for TSY-110
31 August 2026 - Formosa Pharmaceuticals, Inc. (TWSE: 6838), a Taiwan-based biopharmaceutical company, announced on Friday that it has submitted a Clinical Trial Application (CTA) to European regulatory authorities to conduct a pivotal clinical trial...
Juul Labs issues marketing granted orders for next generation JUUL2 System with tobacco- and menthol-flavoured pods
31 August 2026 - US-based electronic cigarette company Juul Labs announced on Friday that the United States Food and Drug Administration has issued marketing granted orders for the company's next generation JUUL2 System with tobacco- and menthol...